Lecture by Prof. Satoshi Uchida, Tokyo Medical and Dental University at the World Vaccine Congress 2024, USA Research on mRNA vaccines using DAICEL's "Actranza® lab."
On April 4, 2024, at the World Vaccine Congress 2024 (Washington, D.C., USA, April 1-4, 2024), Professor Satoshi Uchida of the Department of Advanced Nanomedical Engineering, Medical Research Institute, Tokyo Medical and Dental University (TMDU), gave a lecture on research results using "Actranza® lab.", a novel administration device developed by DAICEL Corporation (President and CEO: Yoshimi Ogawa; Head Office: Osaka, Japan; hereinafter “DAICEL”) for use in animal testing.
Paper on this subject
Carrier-free mRNA vaccine induces robust immunity against SARS-CoV-2 in mice and non-human primates without systemic reactogenicity
Saed Abbasi, Miki Matsui-Masai, Fumihiko Yasui, Akimasa Hayashi, Theofilus A. Tockery, Yuki Mochida, Shiro Akinaga, Michinori Kohara, Kazunori Kataoka, Satoshi Uchida, Molecular Therapy, in press
http://doi.org/10.1016/j.ymthe.2024.03.022
Paper on this subject
Carrier-free mRNA vaccine induces robust immunity against SARS-CoV-2 in mice and non-human primates without systemic reactogenicity
Saed Abbasi, Miki Matsui-Masai, Fumihiko Yasui, Akimasa Hayashi, Theofilus A. Tockery, Yuki Mochida, Shiro Akinaga, Michinori Kohara, Kazunori Kataoka, Satoshi Uchida, Molecular Therapy, in press
http://doi.org/10.1016/j.ymthe.2024.03.022
